Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 286
Filtrar
2.
Radiologia (Engl Ed) ; 66(2): 105-106, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38614526
3.
Semergen ; 50(6): 102220, 2024 Mar 29.
Artigo em Inglês | MEDLINE | ID: mdl-38554607

RESUMO

OBJECTIVE: To determine the prevalence, impact and management of hypertension-mediated organ damage (HMOD) according to the presence of type 2 diabetes (T2DM). METHODS: IBERICAN is an ongoing multicenter, observational and prospective study, including outpatients aged 18-85 years who attended the Primary Care setting in Spain. In this study, the prevalence, impact and management of HMOD according to the presence of T2DM at baseline were analyzed. RESULTS: At baseline, 8066 patients (20.2% T2DM, 28.6% HMOD) were analyzed. Among patients with T2DM, 31.7% had hypertension, 29.8% dyslipidemia and 29.4% obesity and 49.3% had ≥1 HMOD, mainly high pulse pressure (29.6%), albuminuria (16.2%) and moderate renal impairment (13.6%). The presence of T2DM significantly increased the risk of having CV risk factors and HMOD. Among T2DM population, patients with HMOD had more dyslipidemia (78.2% vs 70.5%; P=0.001), hypertension (75.4% vs 66.4%; P=0.001), any CV disease (39.6% vs 16.1%; P=0.001) and received more drugs. Despite the majority of types of glucose-lowering agents were more frequently taken by those patients with HMOD, compared to the total T2DM population, the use of SGLT2 inhibitors and GLP-1 receptor agonists was marginal. CONCLUSIONS: In patients daily attended in primary care setting in Spain, one in five patients had T2DM and nearly half of these patients had HMOD. In patients with T2DM, the presence of HMOD was associated with a higher risk of CV risk factors and CV disease. Despite the very high CV risk, the use of glucose-lowering agents with proven CV benefit was markedly low.

4.
SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.) ; 49(6): [e101998], sept. 2023. ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-224803

RESUMO

En la enfermedad pulmonar obstructiva crónica el síndrome de agudización (SAE) es un episodio de inestabilidad clínica por agravamiento de la limitación espiratoria al flujo aéreo o del proceso inflamatorio subyacente. La gravedad del SAE depende de la estratificación del riesgo basal y la intensidad del episodio agudo. La Atención Primaria es el epicentro del circuito asistencial del SAE, pero puede extenderse al Servicio de Urgencias Extrahospitalarias y al propio hospital dependiendo de la situación clínica, del nivel de gravedad, de la disponibilidad de pruebas complementarias y de los recursos terapéuticos necesarios para cada paciente. El registro de los datos clínicos, antecedentes, factores desencadenantes, tratamiento y evolución de los episodios previos de SAE en la historia clínica electrónica son un aspecto esencial para ajustar el tratamiento actual y prevenir la aparición de futuros episodios (AU)


In chronic obstructive pulmonary disease, an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is an episode of clinical instability due to the worsening of expiratory airflow limitation or of the underlying inflammatory process. The severity of AECOPD depends on baseline risk stratification and the intensity of the acute episode. Primary Care is the epicenter of the AECOPD care circuit, but it can be extended to the out-of-hospital emergency department and the hospital itself depending on the clinical situation, the level of severity, the availability of complementary tests, and the therapeutic resources required for each patient. Recording clinical data, history, triggering factors, treatment, and evolution of previous episodes of AECOPD in the electronic medical record is an essential aspect to adjust current treatment and prevent the occurrence of future episodes (AU)


Assuntos
Humanos , Doença Pulmonar Obstrutiva Crônica/terapia , Serviços Médicos de Emergência , Exacerbação dos Sintomas , Protocolos Clínicos
5.
Semergen ; 49(6): 101998, 2023 Sep.
Artigo em Espanhol | MEDLINE | ID: mdl-37295262

RESUMO

In chronic obstructive pulmonary disease, an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is an episode of clinical instability due to the worsening of expiratory airflow limitation or of the underlying inflammatory process. The severity of AECOPD depends on baseline risk stratification and the intensity of the acute episode. Primary Care is the epicenter of the AECOPD care circuit, but it can be extended to the out-of-hospital emergency department and the hospital itself depending on the clinical situation, the level of severity, the availability of complementary tests, and the therapeutic resources required for each patient. Recording clinical data, history, triggering factors, treatment, and evolution of previous episodes of AECOPD in the electronic medical record is an essential aspect to adjust current treatment and prevent the occurrence of future episodes.


Assuntos
Doença Pulmonar Obstrutiva Crônica , Humanos , Doença Pulmonar Obstrutiva Crônica/terapia , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Serviço Hospitalar de Emergência
6.
Rev. neurol. (Ed. impr.) ; 76(5): 167-175, Ene-Jun. 2023. tab, ilus
Artigo em Espanhol | IBECS | ID: ibc-216663

RESUMO

Introducción: Los cuidados paliativos hacen referencia al tratamiento dirigido a la identificación precoz e impecable del dolor y otros problemas físicos, psicosociales y espirituales que limitan la calidad de vida de la persona, la familia y sus cuidadores. El objetivo de este artículo es identificar las intervenciones paliativas utilizadas para la valoración y el control de síntomas en personas con enfermedad de Parkinson (EP) avanzada. Materiales y métodos: Se desarrolló una revisión sistémica de la bibliografía aplicando los pasos propuestos por Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). La búsqueda se orientó a partir de una pregunta de revisión estructurada y se incluyeron estudios originales de pacientes con EP avanzada publicados en bases de datos como Medline y Google Scholar entre 2010 a 2021. Resultados: Se revisaron 31 estudios en texto completo y se excluyeron 12 estudios por no alcanzar los criterios de calidad. En total, se incluyeron 19 trabajos en esta revisión sistemática, identificando 10 herramientas clínicas para valorar las necesidades paliativas en EP avanzada, cuatro intervenciones farmacológicas, y tres intervenciones no farmacológicas centradas en disminuir síntomas motores, mejorar la calidad de vida y evitar el estado on/off. Un estudio notificó la derivación del paciente a terapias complementarias y asistidas por dispositivos. Conclusión: Como parte del abordaje paliativo se han descrito un conjunto de herramientas para identificar síntomas y valorar necesidades de atención paliativa. Las intervenciones en la EP avanzada se enfocan en el control de los síntomas motores y no motores para disminuir el impacto de la enfermedad sobre la calidad de vida.(AU)


Introduction: Palliative care refers to treatment aimed at the early and comprehensive identification of pain and other physical, psychosocial and spiritual problems that limit the quality of life of the person, their family and their caregivers. The aim of this article is to identify palliative interventions used for the assessment and control of symptoms in people with advanced Parkinson's disease (PD). Materials and methods: A systematic review of the literature was conducted following the steps proposed by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). The search was guided by a structured review question and included original studies of patients with advanced PD published in databases such as Medline and Google Scholar between 2010 and 2021. Results: Thirty-one full-text studies were reviewed and 12 were excluded due to not meeting quality criteria. A total of 19 papers were included in this systematic review, which identified 10 clinical tools to assess palliative needs in advanced PD, four pharmacological interventions, and three non-pharmacological interventions focused on reducing motor symptoms, improving quality of life and avoiding the on/off state. One study reported the referral of patients to complementary and device-assisted therapies. Conclusion: As part of the palliative approach, a set of tools for identifying symptoms and assessing palliative care needs have been described. Interventions in advanced PD focus on the control of motor and non-motor symptoms so as to reduce the impact of the disease on quality of life.(AU)


Assuntos
Humanos , Cuidados Paliativos , Doença de Parkinson , Avaliação de Processos e Resultados em Cuidados de Saúde , Manejo da Dor , Avaliação de Sintomas , Neurologia , Doenças do Sistema Nervoso
7.
Rev Neurol ; 76(5): 167-175, 2023 03 01.
Artigo em Espanhol | MEDLINE | ID: mdl-36843177

RESUMO

INTRODUCTION: Palliative care refers to treatment aimed at the early and comprehensive identification of pain and other physical, psychosocial and spiritual problems that limit the quality of life of the person, their family and their caregivers. The aim of this article is to identify palliative interventions used for the assessment and control of symptoms in people with advanced Parkinson's disease (PD). MATERIALS AND METHODS: A systematic review of the literature was conducted following the steps proposed by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). The search was guided by a structured review question and included original studies of patients with advanced PD published in databases such as Medline and Google Scholar between 2010 and 2021. RESULTS: Thirty-one full-text studies were reviewed and 12 were excluded due to not meeting quality criteria. A total of 19 papers were included in this systematic review, which identified 10 clinical tools to assess palliative needs in advanced PD, four pharmacological interventions, and three non-pharmacological interventions focused on reducing motor symptoms, improving quality of life and avoiding the on/off state. One study reported the referral of patients to complementary and device-assisted therapies. CONCLUSION: As part of the palliative approach, a set of tools for identifying symptoms and assessing palliative care needs have been described. Interventions in advanced PD focus on the control of motor and non-motor symptoms so as to reduce the impact of the disease on quality of life.


TITLE: Cuidados paliativos para personas con enfermedad de Parkinson avanzada. Revisión sistemática.Introducción. Los cuidados paliativos hacen referencia al tratamiento dirigido a la identificación precoz e impecable del dolor y otros problemas físicos, psicosociales y espirituales que limitan la calidad de vida de la persona, la familia y sus cuidadores. El objetivo de este artículo es identificar las intervenciones paliativas utilizadas para la valoración y el control de síntomas en personas con enfermedad de Parkinson (EP) avanzada. Materiales y métodos. Se desarrolló una revisión sistémica de la bibliografía aplicando los pasos propuestos por Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). La búsqueda se orientó a partir de una pregunta de revisión estructurada y se incluyeron estudios originales de pacientes con EP avanzada publicados en bases de datos como Medline y Google Scholar entre 2010 a 2021. Resultados. Se revisaron 31 estudios en texto completo y se excluyeron 12 estudios por no alcanzar los criterios de calidad. En total, se incluyeron 19 trabajos en esta revisión sistemática, identificando 10 herramientas clínicas para valorar las necesidades paliativas en EP avanzada, cuatro intervenciones farmacológicas, y tres intervenciones no farmacológicas centradas en disminuir síntomas motores, mejorar la calidad de vida y evitar el estado on/off. Un estudio notificó la derivación del paciente a terapias complementarias y asistidas por dispositivos. Conclusión. Como parte del abordaje paliativo se han descrito un conjunto de herramientas para identificar síntomas y valorar necesidades de atención paliativa. Las intervenciones en la EP avanzada se enfocan en el control de los síntomas motores y no motores para disminuir el impacto de la enfermedad sobre la calidad de vida.


Assuntos
Cuidados Paliativos , Doença de Parkinson , Humanos , Qualidade de Vida , Doença de Parkinson/terapia , Dor , Cuidadores
8.
Radiologia (Engl Ed) ; 64 Suppl 1: 1, 2022 03.
Artigo em Inglês | MEDLINE | ID: mdl-36052938
9.
Radiología (Madr., Ed. impr.) ; 64(3): 193-194, May-Jun 2022.
Artigo em Espanhol | IBECS | ID: ibc-204576
10.
Lett Appl Microbiol ; 75(2): 345-354, 2022 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-35486037

RESUMO

Plants growing in metal-polluted sites can be a source of micro-organisms suitable for bio-assisted phytoremediation strategies. In this work, three endophytic fungi from the roots of Poa stuckertii and Poa pratensis, two grasses that naturally colonize a Lead-Zinc tailing storage facility in Southern Chile, were isolated and identified. The leachate of the tailing sands showed a Pb content of 1·36 ± 0·71 ppm, and a pH of 7·3. By amplifying the ITS1/ITS4 region of fungal ribosomal DNA, the isolates were identified as Bjerkandera sp., Microdochium sp. and Sarocladium sp. When the growth media was supplemented with 50 ppm of Pb at pH 4·5, Microdochium sp. showed an 80% decrease in the biomass, but the biomass production of Bjerkandera sp. and Sarocladium sp. was not affected by the same treatment. The accumulation of Pb in Microdochium sp. increased as a function of the concentration of the metal in the growth media, between 48·3 and 241·3 µmol l-1 . We showed that two Poaceae plants growing on a Lead-Zinc tailing storage facility are a source of endophyte fungi and that Pb had a differential effect on the growth of the isolated fungi independent of the plant of origin.


Assuntos
Metais Pesados , Poluentes do Solo , Biodegradação Ambiental , Fungos/genética , Chumbo , Raízes de Plantas/microbiologia , Solo/química , Poluentes do Solo/análise , Zinco/análise
11.
Clín. investig. ginecol. obstet. (Ed. impr.) ; 49(2): 1-6, Abril - Junio, 2022. tab
Artigo em Espanhol | IBECS | ID: ibc-203195

RESUMO

La evaluación del factor masculino es obligada durante la consulta de una pareja a un especialista en fertilidad. Sin embargo, para muchos hombres el proceso de recolección de la muestra de semen en el laboratorio puede ser estresante, por lo que actualmente se encuentran disponibles pruebas caseras para el análisis seminal. El objetivo de esta revisión narrativa de la literatura es dar a conocer las pruebas que permiten valorar la calidad seminal en casa.En el mercado existen 11pruebas que proporcionan información sobre uno o 2parámetros seminales. Así mismo, se pueden encontrar pruebas que utilizan teléfonos inteligentes dando resultados de concentración y movilidad espermáticas, algunas utilizan los parámetros seminales estipulados por la Organización Mundial de la Salud y su precio se encuentra en un rango de USD 15 a USD 90; además de la privacidad y la comodidad, pueden revelar alteraciones en la calidad seminal de forma temprana. Entre sus limitaciones, se indican la poca información que proporcionan, además, la recolección y la manipulación pueden afectar los resultados. En conclusión, aunque las pruebas caseras pueden alertar tempranamente de alteraciones en la calidad seminal, no reemplazan el análisis exhaustivo del laboratorio, por lo que se pueden utilizar como un complemento en la evaluación del factor masculino.


Evaluation of the male factor is critical when a couple consults with a fertility specialist. However, for many men the process of collecting a semen sample for laboratory analysis can be stressful, which is why home semen tests are now available. This narrative review aimed to present the tests available to evaluate male fertility at home.Eleven tests on the market provide information on one or 2seminal parameters. Likewise, tests can be found that use smartphones to obtain sperm concentration and motility results; some use the parameters stipulated by the World Health Organization and their price range is between USD 15 and USD 90. They have the advantage of privacy and comfort.Their limitations include the fact that they provide little information, and that collection and handling can affect the results. In conclusion, home tests can be used in the first instance to reveal alterations in sperm quality, especially when there are risk factors. However, these tests are not a substitute for laboratory analysis, therefore they can be used as an adjunct in evaluating the male factor.


Assuntos
Humanos , Masculino , Adulto , Ciências da Saúde , Fertilidade , Sêmen , Recuperação Espermática , Manejo de Espécimes , Análise do Sêmen
12.
SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.) ; 48(1): 14-22, Ene. - Feb. 2022. tab
Artigo em Espanhol | IBECS | ID: ibc-205196

RESUMO

Objetivos: Conocer las actitudes y conocimientos de los usuarios respecto a cómo y dónde se desechan los inhaladores tras finalizar su uso, y describir su opinión sobre el uso de inhaladores recargables. Métodos: Estudio transversal, multicéntrico y de opinión, diseñado para conocer el comportamiento y actitudes respecto al circuito de desecho de los inhaladores y a la utilización de inhaladores recargables. La información se obtuvo mediante la aplicación de un cuestionario ad hoc de conocimientos y actitudes, conteniendo datos de uso y reciclado de inhaladores. Resultados: Se incluyeron 303 sujetos (57,5 ± 19,9 años; tiempo de empleo de inhaladores 9,6±9,8 años; asma/EPOC: 46,2/25,7%). El inhalador más empleado fue el aerosol presurizado en suspensión (30,5%). La mayoría otorgaban una elevada importancia al reciclado de inhaladores (7,75±2,76, sobre 10), y a disponer cada seis meses del mismo inhalador recargable mensualmente (7,77±2,79, sobre 10). El 33% refería haber sido informado alguna vez sobre dónde depositar el inhalador. En cuanto al reciclado, el 42,9% lo hacía en el punto SIGRE de la farmacia. Respecto al destino final de los inhaladores, el 43,6% creía que los dispositivos entregados se reciclaban o destruían y un 35,3% desconocía qué ocurre con los inhaladores después de depositarlos en el punto SIGRE. Conclusiones: A pesar de que los usuarios consideran importante el reciclado de inhaladores y disponer de inhaladores recargables, un porcentaje significativo no los deposita en el punto SIGRE, no han sido informados sobre el lugar correcto de depósito, y desconocen qué ocurre con los inhaladores desechados. Son necesarias campañas de información (AU)


Objectives: To assess users’ attitudes and knowledge of users about how and where inhalers are removed after finalizing their use, and to describe their opinion about utilizing re-usable inhalers. Methods: Cross-sectional, multi-center, and opinion survey, conducted to assess behavior and attitudes regarding the disposal of inhalers recycling and the use of re-usable inhalers, through the application of an ad hoc questionnaire about the knowledge and attitudes, with data about the use and recycling of inhalers. Results: A total of 303 subjects (57.5±19.9 years; time of inhalers’ use 9.6±9.8 years; asthma/COPD: 46.2%/25.7%) were included. Pressurized metered-dose inhalers were the most commonly used inhalers (30.5%). Most users considered the recycling of inhalers to be very important (7.75±2.76, out of 10), and rated highly the availability of having a monthly rechargeable inhaler every 6 months (7.77±2.79, out of 10). Only 33% of users had been informed by their healthcare professionals about the place of delivering the inhaler. With respect to recycling, 42.9% of all users recycled in the SIGRE point of the pharmacy. Regarding the final destination of inhalers, 43.6% thought that the removed inhalers were recycled or destroyed, but 35.3% did not know what would happen to the inhalers after placing in the SIGRE point. Conclusions: Despite users considered the importance of inhalers recycling and the availability of re-usable inhalers, a significant proportion does not recycle in the SIGRE point, has not been informed about the appropriate place of delivering the inhaler and ignores what happens to inhalers. Information campaigns are warranted (AU)


Assuntos
Humanos , Asma/tratamento farmacológico , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Conhecimentos, Atitudes e Prática em Saúde , Administração por Inalação , Sprays Orais , Estudos Transversais
13.
Sci Rep ; 12(1): 864, 2022 01 17.
Artigo em Inglês | MEDLINE | ID: mdl-35039560

RESUMO

Diseases caused by the fungus Sclerotinia sclerotiorum are managed mainly through fungicide applications in canola and dry bean. Accurate estimation of the risk of disease development on these crops could help farmers make spraying decisions. Five machine learning (ML) models were evaluated in classification and regression modes for predicting disease establishment under different air temperatures and leaf wetness duration conditions. Model algorithms were trained and tested using 20-fold cross validation. Correspondence between predicted and observed values were measured using Cohen's Kappa (classification) and Lin's concordance coefficients (regression). The artificial neural network (ANN) algorithms had average accuracies ≥ 89% (classification) and R2 ≥ 88% (regression) on canola and dry bean and their correspondence agreements were ≥ 0.83, which is considered substantial to almost perfect. In contrast, logistic regression algorithms had accuracies of 88% for dry bean and 78% for canola; other models were similarly inconsistent. Implementation of ANN models in disease warning systems could help farmers with spraying decisions. At the same time, these models provide insights on temperature and leaf wetness requirements for development of S. sclerotiorum diseases in these crops. Results of this study show the potential of ML models as tools for epidemiological studies on other pathosystems.


Assuntos
Ascomicetos/fisiologia , Brassica napus/microbiologia , Produtos Agrícolas/microbiologia , Fabaceae/microbiologia , Aprendizado de Máquina , Doenças das Plantas/microbiologia , Doenças das Plantas/prevenção & controle , Agricultura/métodos , Fungicidas Industriais , Modelos Logísticos , Redes Neurais de Computação , Medição de Risco , Temperatura
14.
Semergen ; 48(1): 14-22, 2022.
Artigo em Espanhol | MEDLINE | ID: mdl-34479795

RESUMO

OBJECTIVES: To assess users' attitudes and knowledge of users about how and where inhalers are removed after finalizing their use, and to describe their opinion about utilizing re-usable inhalers. METHODS: Cross-sectional, multi-center, and opinion survey, conducted to assess behavior and attitudes regarding the disposal of inhalers recycling and the use of re-usable inhalers, through the application of an ad hoc questionnaire about the knowledge and attitudes, with data about the use and recycling of inhalers. RESULTS: A total of 303 subjects (57.5±19.9 years; time of inhalers' use 9.6±9.8 years; asthma/COPD: 46.2%/25.7%) were included. Pressurized metered-dose inhalers were the most commonly used inhalers (30.5%). Most users considered the recycling of inhalers to be very important (7.75±2.76, out of 10), and rated highly the availability of having a monthly rechargeable inhaler every 6 months (7.77±2.79, out of 10). Only 33% of users had been informed by their healthcare professionals about the place of delivering the inhaler. With respect to recycling, 42.9% of all users recycled in the SIGRE point of the pharmacy. Regarding the final destination of inhalers, 43.6% thought that the removed inhalers were recycled or destroyed, but 35.3% did not know what would happen to the inhalers after placing in the SIGRE point. CONCLUSIONS: Despite users considered the importance of inhalers recycling and the availability of re-usable inhalers, a significant proportion does not recycle in the SIGRE point, has not been informed about the appropriate place of delivering the inhaler and ignores what happens to inhalers. Information campaigns are warranted.


Assuntos
Asma , Doença Pulmonar Obstrutiva Crônica , Administração por Inalação , Asma/tratamento farmacológico , Estudos Transversais , Humanos , Nebulizadores e Vaporizadores , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico
15.
Rev. chil. neuro-psiquiatr ; 59(4): 289-301, dic. 2021. tab
Artigo em Espanhol | LILACS | ID: biblio-1388411

RESUMO

OBJETIVO: Determinar la asociación entre el consumo de bebidas energizantes y síntomas de insomnio en estudiantes de medicina de una universidad en Lima, Perú. MATERIALES Y MÉTODO: El tipo de estudio realizado es transversal analítico. La población objetivo fueron los estudiantes de medicina de una universidad peruana ubicada en Lima sur de segundo y quinto año. Hubo 289 participantes en el estudio. Se utilizó una encuesta compuesta por un cuestionario sobre el consumo de bebidas energizantes y el Insomnia Severity Index, del cual se determinó un punto de corte de 15 para considerar la presencia de síntomas de insomnio. El análisis multivariado crudo y ajustado se realizó usando la regresión de Poisson con varianza robusta ajustado para sexo, edad, consumo de café, y antecedente de ansiedad y depresión, para obtener el PR (Razón de Prevalencias) con un intervalo de confianza de 95%. RESULTADOS Y DISCUSIÓN: La prevalencia de síntomas de insomnio en la muestra estudiada fue de 21,80%, mientras que la de consumo de bebidas energizantes fue de 39,45%. Se encontró asociación significativa (p=0,008) entre el consumo de este tipo de bebidas y la presencia de síntomas de insomnio. Además, se encontró que los estudiantes que consumen bebidas energizantes tuvieron 1,78 veces más probabilidad de presentar síntomas de insomnio (IC95%: 1,13-2,82), en comparación con los que no consumieron bebidas energizantes (p=0,013). CONCLUSIONES: Existe asociación entre el consumo de bebidas energizantes y síntomas de insomnio.


OBJECTIVE: To determine the association between the consumption of energy drinks and symptoms of insomnia in medical students of a university in Lima, Peru. Materials and METHODS: This study is cross-sectional analytical. The target population was the second-and fifth-year medical students of a private Peruvian university in southern Lima. There were 289 participants in this study. For this study, a survey composed of a questionnaire about the consumption of energy drinks and the Insomnia Severity Index were used, from which a cut-off point of 15 was determined to consider the presence of insomnia symptoms. The multivariate crude and adjusted analysis were done with Poisson regression with robust variance adjusted for sex, age, coffee consumption, previous diagnosis of depression and previous diagnosis of anxiety; to calculate the PR (Prevalence Ratio) with a 95% CI. RESULTS AND DISCUSSION: The prevalence of insomnia symptoms in the sample studied was 21,80%, while the consumption of energy drinks was 39,45%. A significant association was found (p = 0.008) between the consumption of this type of drinks and the presence of insomnia symptoms. In addition, it was found that students who consumed energy drinks were 1,78 times more likely to have symptoms of insomnia (95% CI: 1,13-2,82), compared to those who did not consume energy drinks (p=<0,013). CONCLUSIONS: There is an association between the consumption of energy drinks and symptoms of insomnia.


Assuntos
Humanos , Masculino , Feminino , Adulto Jovem , Estudantes de Medicina , Bebidas Energéticas/efeitos adversos , Distúrbios do Início e da Manutenção do Sono/etiologia , Peru , Universidades , Estudos Transversais , Inquéritos e Questionários
18.
Environ Toxicol Pharmacol ; 86: 103654, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-33823299

RESUMO

The increasing use of metal oxide nanoparticles (MONPs) as TiO2 NPs or ZnO NPs has led to environmental release and human exposure. The respiratory system, effects on lamellar bodies and surfactant protein A (SP-A) of pneumocytes, can be importantly affected. Exposure of human alveolar epithelial cells (A549) induced differential responses; a higher persistence of TiO2 in cell surface and uptake (measured by Atomic Force Microscopy) and sustained inflammatory response (by means of TNF-α, IL-10, and IL-6 release) and ROS generation were observed, whereas ZnO showed a modest response and low numbers in cell surface. A reduction in SP-A levels at 24 h of exposure to TiO2 NPs (concentration-dependent) or ZnO NPs (the higher concentration) was also observed, reversed by blocking the inflammatory response (by the inhibition of IL-6). Loss of SP-A represents a relevant target of MONPs-induced inflammatory response that could contribute to cellular damage and loss of lung function.


Assuntos
Células Epiteliais Alveolares/efeitos dos fármacos , Nanopartículas/toxicidade , Proteína A Associada a Surfactante Pulmonar/antagonistas & inibidores , Titânio/toxicidade , Óxido de Zinco/toxicidade , Células A549 , Células Epiteliais Alveolares/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Citocinas/metabolismo , Humanos , Inflamação/induzido quimicamente , Inflamação/metabolismo , Pulmão , Proteína A Associada a Surfactante Pulmonar/metabolismo , Espécies Reativas de Oxigênio/metabolismo
20.
Radiologia (Engl Ed) ; 63(3): 209-217, 2021.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-33678459

RESUMO

BACKGROUND AND AIMS: Bibliometrics makes it possible to measure the relative importance of a scientific journal in its field. The current study analyzed the scientific publications in Radiología and the bibliometric parameters of the journal in the period comprising 2010 through 2019. MATERIALS AND METHODS: We reviewed the bibliometrics for Radiología through information obtained from three sources: Scopus, the online version of the journal, and the publisher (Elsevier). We retrospectively analyzed aspects related to the editorial process (final decision and speed), the articles published (type, subspecialty of radiology, and imaging technique), the trends in citation and various indices (CiteScore, SNIP, and SJR), visibility, downloads, author characteristics (geographical origin and institutional collaboration), and the most cited articles. RESULTS: The number of articles published in Radiología gradually decreased during the decade, and the time to publication increased. Original research articles account for the largest share of the articles published. The most common subject areas were radiology of the digestive tract and neuroradiology. Nevertheless, the bibliometric indicators and the number of downloads of articles increased every year. Regarding the authorship of the articles published, although authors from Spain predominate, the participation of authors from other countries became increasingly common. Collaboration among different institutions also became increasingly common in the period analyzed. CONCLUSIONS: This review shows the progression of the journal's scientific work and some aspects that must be addressed to favor the growth of Radiología.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...